Biblio

Found 20 results
Filters: Keyword is Cataplexy  [Clear All Filters]
2014
Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH.  2014.  Cataplexy--clinical aspects, pathophysiology and management strategy.. Nature Reviews Neurology. 10(7):386-95.
2013
John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M et al..  2013.  Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.. Annals of Neurology. 74(6):786-93.
2011
Siegel JM.  2011.  REM sleep: a biological and psychological paradox.. Sleep Med Rev. 15(3):139-42.
Wu M-F, Nienhuis R, Maidment N, Lam HA, Siegel JM.  2011.  Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.. J Neurosci. 31(17):6305-10.
2009
Scammell TE, Willie JT, Guilleminault C, Siegel JM.  2009.  A consensus definition of cataplexy in mouse models of narcolepsy.. Sleep. 32(1):111-6.
Thannickal TC, Nienhuis R, Siegel JM.  2009.  Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.. Sleep. 32(8):993-8.
2004
John J, Wu M-F, Boehmer LN, Siegel JM.  2004.  Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior.. Neuron. 42(4):619-34.
1999
Wu MF, Gulyani SA, Yau E, Mignot E, Phan B, Siegel JM.  1999.  Locus coeruleus neurons: cessation of activity during cataplexy.. Neuroscience. 91(4):1389-99.
Siegel JM.  1999.  Narcolepsy: a key role for hypocretins (orexins). Cell. 98(4):409-12.
1998
Reid MS, Nishino S, Tafti M, Siegel JM, Dement WC, Mignot E.  1998.  Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.. Exp Neurol. 151(1):89-104.
1996
Reid MS, Tafti M, Nishino S, Sampathkumaran R, Siegel JM, Mignot E.  1996.  Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine.. Brain Res. 733(1):83-100.
1995
Nishino S, Tafti M, Reid MS, Shelton J, Siegel JM, Dement WC, Mignot E.  1995.  Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.. J Neurosci. 15(7 Pt 1):4806-14.
1994
Reid MS, Tafti M, Geary JN, Nishino S, Siegel JM, Dement WC, Mignot E.  1994.  Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.. Neuroscience. 59(3):511-22.
Reid MS, Siegel JM, Dement WC, Mignot E.  1994.  Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.. Neuroscience. 59(3):523-30.
Reid MS, Tafti M, Nishino S, Siegel JM, Dement WC, Mignot E.  1994.  Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors.. Sleep. 17(5):424-35.
1992
Siegel JM, Nienhuis R, Fahringer HM, Chiu C, Dement WC, Mignot E, Lufkin R.  1992.  Activity of medial mesopontine units during cataplexy and sleep-waking states in the narcoleptic dog.. J Neurosci. 12(5):1640-6.
1989
Siegel JM, Tomaszewski KS, Fahringer H, Cave G, Kilduff T, Dement WC.  1989.  Heart rate and blood pressure changes during sleep-waking cycles and cataplexy in narcoleptic dogs.. Am J Physiol. 256(1 Pt 2):H111-9.
1986
Siegel JM, Fahringer H, Tomaszewski KS, Kaitin K, Kilduff T, Dement WC.  1986.  Heart rate and blood pressure changes associated with cataplexy in canine narcolepsy.. Sleep. 9(1 Pt 2):216-21.